Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking | MicrobiomeTrials← Back to trialsNCT06235567
Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking
ENROLLING_BY_INVITATIONPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2025-04-11Est. Completion: 2026-12
Enrollment target: 20 participants Locations- Mission Bay Hospital, San Francisco, California, United States
- UCSF Pediatric Ophthalmology, San Francisco, California, United States
- Wayne and Gladys Center for Vision, San Francisco, California, United States
Other microbiome trials you might be interested in
Keratoconus, Stable
This project aims at non-progressive keratoconus patients with unsatisfactory visual acuity corrected by spectacles, and…
Guangzhou, ChinaCompleted Sep 1, 2026
Corneal Epithelial Wound HealingPost Operative Pain
The goal of this clinical trial was to learn if topical insulin eye drops affected corneal epithelial wound healing afte…
Cairo, EgyptCompleted May 30, 2025